Side Effects of GLP-1 Medications, Like Ozempic and Mounjaro, Could Result in Bone Density Loss: Study
A combination of both GLP-1 medications and exercise were needed to achieve weight loss without also losing bone density, researchers found.
A combination of both GLP-1 medications and exercise were needed to achieve weight loss without also losing bone density, researchers found.
Claim joins a growing number of Ozempic Lawsuits being pursued by users, alleging that the drug maker failed to adequately disclose the severity of gastrointestinal side effects and long-term problems users may experience.
New MDL Judge has set a status conference for June 10, at which time she will meet with parties involved in Ozempic lawsuits for the first time.
Researchers say the sudden metabolic and caloric weight loss caused by Ozempic, combined with direct effects the drug has on brain functions may cause impulse control disorders.
An Ozempic lawsuits "Science Day" scheduled for next month has been cancelled, pending reassignment of the MDL to a new judge.
Lawsuit claims Novo Nordisk failed to warn that the risk of Wegovy gastroparesis side effects was dose-specific, meaning the higher the dose, the more likely stomach paralysis would occur.
Ahead of the Science Day, Judge Pratter has appointed 24 plaintiffs attorneys to serve in various leadership positions during the MDL proceedings
There was little difference in thyroid cancer rates among Ozempic and Mounjaro users, compared to those who took Januvia, Onglyza and similar diabetes medications.
Lawsuit indicates that side effect of Wegovy caused a Kentucky woman to develop stomach paralysis and a bowel obstruction, which resulted in multiple days of hospitaliation and left her with long-term gastrointestinal damage
The lead lawyers in the Ozempic MDL may choose up to 25 additional attorneys to serve on the Plaintiffs' Committee, who will take certain actions during pretrial proceedings that benefit plaintiffs in all GLP-1 lawsuits